Cargando…

Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City

Pharmacoepidemiological research about antibiotics is supported by the World Health Organization (WHO), but data regarding antibiotic prevalence based on actual prescriptions and dosing patterns are insufficient. The aims were: (i) To estimate the prevalence and prescribed daily dose (PDD) of antibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Huesca, Ramiro, Lerma, Abel, Guzmán-Saldaña, Rebeca M.E, Lerma, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168224/
https://www.ncbi.nlm.nih.gov/pubmed/31968527
http://dx.doi.org/10.3390/antibiotics9010038
_version_ 1783523638737108992
author Sánchez-Huesca, Ramiro
Lerma, Abel
Guzmán-Saldaña, Rebeca M.E
Lerma, Claudia
author_facet Sánchez-Huesca, Ramiro
Lerma, Abel
Guzmán-Saldaña, Rebeca M.E
Lerma, Claudia
author_sort Sánchez-Huesca, Ramiro
collection PubMed
description Pharmacoepidemiological research about antibiotics is supported by the World Health Organization (WHO), but data regarding antibiotic prevalence based on actual prescriptions and dosing patterns are insufficient. The aims were: (i) To estimate the prevalence and prescribed daily dose (PDD) of antibiotics in outpatients from Mexico City and (ii) to compare the PDD against the defined daily dose (DDD), as established by the WHO. The study included 685 prescriptions of antibiotics selected randomly from five geographical zones of Mexico City. Drug, dose, frequency, and duration of treatment were obtained from each prescription. PDD values of each antibiotic drug were calculated as the average of the daily doses. Sub-use and overuse were determined by the ratio PDD/DDD for each prescription. The most prescribed antibiotics to outpatients from Mexico City included six pharmacological groups: quinolones (28%), penicillins (23%), cephalosporins (17%), macrolides (10%), lincosamides (9%), and sulfonamides (4%). Both overuse and sub-use were high (55% and 63%, respectively). In conclusion, most of the antibiotics with a high prevalence of prescription also had a high rate of either sub-use or overuse, with prescribed doses that significantly differ with their corresponding DDD. The dosing variation has important clinical implications since it denotes low prescription control.
format Online
Article
Text
id pubmed-7168224
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71682242020-04-22 Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City Sánchez-Huesca, Ramiro Lerma, Abel Guzmán-Saldaña, Rebeca M.E Lerma, Claudia Antibiotics (Basel) Article Pharmacoepidemiological research about antibiotics is supported by the World Health Organization (WHO), but data regarding antibiotic prevalence based on actual prescriptions and dosing patterns are insufficient. The aims were: (i) To estimate the prevalence and prescribed daily dose (PDD) of antibiotics in outpatients from Mexico City and (ii) to compare the PDD against the defined daily dose (DDD), as established by the WHO. The study included 685 prescriptions of antibiotics selected randomly from five geographical zones of Mexico City. Drug, dose, frequency, and duration of treatment were obtained from each prescription. PDD values of each antibiotic drug were calculated as the average of the daily doses. Sub-use and overuse were determined by the ratio PDD/DDD for each prescription. The most prescribed antibiotics to outpatients from Mexico City included six pharmacological groups: quinolones (28%), penicillins (23%), cephalosporins (17%), macrolides (10%), lincosamides (9%), and sulfonamides (4%). Both overuse and sub-use were high (55% and 63%, respectively). In conclusion, most of the antibiotics with a high prevalence of prescription also had a high rate of either sub-use or overuse, with prescribed doses that significantly differ with their corresponding DDD. The dosing variation has important clinical implications since it denotes low prescription control. MDPI 2020-01-20 /pmc/articles/PMC7168224/ /pubmed/31968527 http://dx.doi.org/10.3390/antibiotics9010038 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sánchez-Huesca, Ramiro
Lerma, Abel
Guzmán-Saldaña, Rebeca M.E
Lerma, Claudia
Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City
title Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City
title_full Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City
title_fullStr Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City
title_full_unstemmed Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City
title_short Prevalence of Antibiotics Prescription and Assessment of Prescribed Daily Dose in Outpatients from Mexico City
title_sort prevalence of antibiotics prescription and assessment of prescribed daily dose in outpatients from mexico city
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168224/
https://www.ncbi.nlm.nih.gov/pubmed/31968527
http://dx.doi.org/10.3390/antibiotics9010038
work_keys_str_mv AT sanchezhuescaramiro prevalenceofantibioticsprescriptionandassessmentofprescribeddailydoseinoutpatientsfrommexicocity
AT lermaabel prevalenceofantibioticsprescriptionandassessmentofprescribeddailydoseinoutpatientsfrommexicocity
AT guzmansaldanarebecame prevalenceofantibioticsprescriptionandassessmentofprescribeddailydoseinoutpatientsfrommexicocity
AT lermaclaudia prevalenceofantibioticsprescriptionandassessmentofprescribeddailydoseinoutpatientsfrommexicocity